Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 48.22
+2.47 (5.40%)
Mar 10, 2026, 10:25 AM CST
SHE:002653 Revenue
Haisco Pharmaceutical Group had revenue of 1.30B CNY in the quarter ending September 30, 2025, with 22.05% growth. This brings the company's revenue in the last twelve months to 4.27B, up 14.72% year-over-year. In the year 2024, Haisco Pharmaceutical Group had annual revenue of 3.72B with 10.92% growth.
Revenue (ttm)
4.27B
Revenue Growth
+14.72%
P/S Ratio
11.88
Revenue / Employee
800.12K
Employees
5,337
Market Cap
50.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.72B | 366.28M | 10.92% |
| Dec 31, 2023 | 3.36B | 339.78M | 11.27% |
| Jan 1, 2023 | 3.02B | 241.98M | 8.73% |
| Jan 1, 2022 | 2.77B | -556.28M | -16.71% |
| Dec 31, 2020 | 3.33B | -607.74M | -15.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Wantai Biological Pharmacy Enterprise | 1.80B |
| Pharmaron Beijing | 13.54B |
| Shanghai Allist Pharmaceuticals | 5.17B |
| Shanghai RAAS Blood Products | 7.95B |
| Hebei Changshan Biochemical Pharmaceutical | 928.01M |
| Chongqing Zhifei Biological Products | 10.91B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.20B |
| Asymchem Laboratories (Tianjin) | 6.29B |